Peter Canoll
- Genetics top 0.1%
- Glioma Diagnosis and Treatment 118
- Developmental Neuroscience top 0.5%
- Neurogenesis and neuroplasticity mechanisms 22
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 18
- MicroRNA in disease regulation 13
- Immunology and Allergy top 1%
- Neurology top 1%
- Neuroblastoma Research and Treatments 14
-
- Meningioma and schwannoma management 15
-
- Radiomics and Machine Learning in Medical Imaging 14
-
- Immune cells in cancer 14
- Co-authors
- Jeffrey N. BruceMarcela C. AssanahJ M MusacchioJames E. GoldmanCharles J. DavidMo ChenJames L. ManleyJoseph Schlessinger
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Peter Canoll
226 papers receiving 12.4k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Genetics 3.2k
- Developmental Neuroscience 741
- Cancer Research 2.7k
- Immunology and Allergy 585
- Neurology 791
Countries citing papers authored by Peter Canoll
This map shows the geographic impact of Peter Canoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Canoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Canoll more than expected).
Fields of papers citing papers by Peter Canoll
This network shows the impact of papers produced by Peter Canoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Canoll. The network helps show where Peter Canoll may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Canoll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 6 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 13 | |
| 4 | 2023 | 15 | |
| 5 | 2023 | 13 | |
| 6 | 2022 | 10 | |
| 7 | 2020 | 29 | |
| 8 | 2019 | 43 | |
| 9 | 2019 | 44 | |
| 10 | 2019 | 43 | |
| 11 | 2018 | 37 | |
| 12 | 2017 | 62 | |
| 13 | 2017 | 132 | |
| 14 | 2016 | 30 | |
| 15 | 2016 | 63 | |
| 16 | 2015 | 29 | |
| 17 | 2014 | 72 | |
| 18 | 2014 | 41 | |
| 19 | 2012 | 25 | |
| 20 | 2011 | 31 |
About Peter Canoll
Peter Canoll is a scholar working on Genetics, Developmental Neuroscience and Cancer Research, having authored 232 papers that have together received 12.5k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (118 papers), Neurogenesis and neuroplasticity mechanisms (22 papers), Cancer, Hypoxia, and Metabolism (18 papers), Meningioma and schwannoma management (15 papers), Neuroblastoma Research and Treatments (14 papers), Radiomics and Machine Learning in Medical Imaging (14 papers), Immune cells in cancer (14 papers) and MicroRNA in disease regulation (13 papers). The work is most often cited by research in Genetics (3.2k citations), Developmental Neuroscience (741 citations) and Cancer Research (2.7k citations). Peter Canoll has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Jeffrey N. Bruce, Marcela C. Assanah, J M Musacchio, James E. Goldman, Charles J. David, Mo Chen, James L. Manley, Joseph Schlessinger, Elior Peles and Gregory D. Plowman. Their work appears in journals such as Neuro-Oncology, Journal of Neuro-Oncology, Neurosurgery, Cancer Research and Acta Neuropathologica Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.